Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
Sclerosteosis is an autosomal recessive sclerosing bone dysplasia characterized by progressive skeletal overgrowth. The majority of affected individuals have been reported in the Afrikaner population of South Africa, where a high incidence of the disorder occurs as a result of a founder effect. Homozygosity mapping in Afrikaner families along with analysis of historical recombinants localized sclerosteosis to an interval of approximately 2 cM between the loci D17S1787 and D17S930 on chromosome 17q12-q21. Here we report two independent mutations in a novel gene, termed "SOST." Affected Afrikaners carry a nonsense mutation near the amino terminus of the encoded protein, whereas an unrelated affected person of Senegalese origin carries a splicing mutation within the single intron of the gene. The SOST gene encodes a protein that shares similarity with a class of cystine knot-containing factors including dan, cerberus, gremlin, prdc, and caronte. The specific and progressive effect on bone formation observed in individuals affected with sclerosteosis, along with the data presented in this study, together suggest that the SOST gene encodes an important new regulator of bone homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in genes that have highly enriched expression in osteocytes cause rare bone and mineral disorders.”
From Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease (2021) · cites this paper as [17]
Citations
Cites
Bone: Formation by Autoinduction
Urist, M. R. (1965) · Science · doi:10.1126/science.150.3698.893 · Cited by 5,546 · cited 1×
“Although this family of morpho-gens was originally identified on the basis of bone-in-ducing activity (Urist 1965), a number of these factors have been shown to be critical for very early stages of embryogenesis and fetal development.”
Prediction of complete gene structures in human genomic DNA
Burge, C., & Karlin, S. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0951 · Cited by 4,228 · cited 8×
“The novel variant gene (designated “P50gsc3”) predicted by GENSCAN was located between markers D17S951 and D17S1860 (fig.”
InfluentialA comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928 · cited 3×
“D17S1793, D17S1789, D17S951, and D17S1860 within the critical region bounded by D17S1787 and D17S930, an interval of ∼ 2 cM (Dib et al. 1996) on the cytogenetic border between the chromosomal bands 17q12–q21.”
Bone morphogenetic proteins: multifunctional regulators of vertebrate development.
Hogan, B. L. (1996) · Genes & Development · doi:10.1101/gad.10.13.1580 · Cited by 1,962
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767 · cited 1×
“Currently there is no effective treatment for the restoration of normal bone mass in individuals with pathologically low skeletal density, and there is a large unmet need for therapy that can increase bone deposition in osteoporosis (Rodan and Martin 2000).”
BackgroundEasy calculations of lod scores and genetic risks on small computers.
Lathrop, M. G., & Lalouel, J.-M. (1984) · Europe PMC (PubMed Central) · Cited by 1,526
Faster sequential genetic linkage computations.
Cottingham, R. W., Idury, R. M., & Schäffer, A. A. (1993) · Europe PMC (PubMed Central) · Cited by 1,364
Nonsense-mediated mRNA decayin health and disease
Frischmeyer, P. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.10.1893 · Cited by 992 · cited 1×
“The relatively low levels of mutant transcripts observed could be the result of nonsense-mediated mRNA decay, as the inclusion of intronic sequence introduced an in-frame nonsense codon (Frischmeyer and Dietz 1999; Hentze and Kulozik 1999).”
BackgroundHomozygosity Mapping: A Way to Map Human Recessive Traits with the DNA of Inbred Children
Lander, E. S., & Botstein, D. (1987) · Science · doi:10.1126/science.2884728 · Cited by 875
FORMATION AND FUNCTION OF SPEMANN'S ORGANIZER
Harland, R., & Gerhart, J. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.611 · Cited by 839 · cited 1×
“In addition, the requirement for the coordinated expression of negative regulators of BMP activity, such as noggin and chordin, as well as members of the dan family, has been well described (Harland and Gerhart 1997; Sasai and De Robertis 1997; Hsu et al. 1998).”
Background
Research works printed but not linked: 3
- Gardner J (1999) Profound childhood deafness in South Africa: a clinical and molecular genetic approach. Ph.D. thesis, University of Cape Town, Cape Town
- Hausen, 1967, Sklerosteose, Vol. 6, 351
- Peitruschka, 1958, Weitere Mitteilungen über die Marmorknochenkrankheit (Albers-Schonbergsche Krankheit) nebst Bemerkungen zur Differentialdiagnose, Klin Monatbl, 132, 509
Cited by
Items 901–1,000 of 1,000
Bone Forming Effect of PTH through Wnt/β-catenin Signaling System
Chung, D. J., & Chung, M. Y. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.6.407
“Sclerostin을 과별현시킨 생쥐에서는 골형 성 감소로 골감소증이 초래되고[17], 사람에서는 상염색체 열성으로 유전되는 Sclerosteosis 및 Van Buchem disease 환자에서 sclerostin 기능 소실 돌연변이에 의해 골 과성장 (bone overgrowth) 및 골강도의 증가를 초래한다[18,19].”
New Avenues in the LRP5-mediated Bone Mass Acquisition
Choi, J. (2012) · Korean Journal of Bone Metabolism · doi:10.11005/kjbm.2012.19.1.1
“SOST은 213개 아미노산으로 구성된 단백질로 아미노산 서열이 쥐, 생쥐 각각 사람의 것과 89%, 88% 정도로 높은 유사성을 보인다.(35,36) 사람에서 높은 골량을 보이는 LRP5-G171V 돌연변이를 Rat 3.”
Meeting report from the 28th annual meeting of the American society for bone and mineral research
Schipani, E., Ferrari, S., Datta, N. S., McCauley, L. K., Vignery, A., Bellido, T., Strewler, G. J., Turner, C. H., Jiang, Y., & Seeman, E. (2006) · BoneKEy-Osteovision · doi:10.1138/20060237
Hopeful monsters and morphogens at the beach
Niswander, L. A., & Anderson, K. V. (2002) · Nature Cell Biology · doi:10.1038/ncb1102-e259 · Cited by 1
Schwärzer, G. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-5023
Localization of BMP receptors in distinct plasma membrane domains and its impact on BMP signaling
Würzburg, J.-M.-U. (2006)
Noncanonical Wnt Signaling in Bone
Long, F. (2010) · Endocrinology and Metabolism · doi:10.3803/enm.2010.25.2.85
BMPs and Wnts in Bone and Cartilage Regeneration
Chen, D., Li, S., & Li, T.-F. (2014) · Mechanical engineering series · doi:10.1007/978-3-319-13266-2_2 · Cited by 1
“…diseases were observed in patients with Lrp5 gain-of-function mutations or Sost loss-of-function mutations (Gong et al. 2001; Boyden et al. 2002; Little et al. 2002; Van Wesenbeeck et al. 2003; Beighton 1976; Beighton et al. 1976; Balemans et al. 2001; Brunkow et al. 2001; Wergedal et al. 2003).”
Tsukinowa, T., Onodera, S., Yoshizawa, Y., Saito, A. M., Muramatsu, T., Furusawa, M., & Azuma, T. (2015) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.24.311
Absorption in Health and Disease
Suzuki, Y., Landowski, C. P., & Hediger, M. A. (2008)
MUTATIONS IN THE WNT MEDIATOR, DVL1, CAUSE AN OSTEOSCLEROTIC FORM OF ROBINOW SYNDROME
Bunn, K. J. (2015) · Otago University Research Archive (University of Otago)
Canonical Wnt Signaling in Hair and Mammary Gland Patterning and Development
Närhi, K. M. (2012) · Helda - University of Helsinki Institutional Repository
Structural and functional characterisation of Dickkopf4 (Dkk4), a key inhibitor of Wnt signalling
Barkell, A. M. (2013) · Figshare
Johnson, M. L., & Recker, R. R. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50019-7 · Cited by 1
Recent progress in the genetics of osteoporosis
Shen, H., Liu, Y., Xiao, P., Xiong, D. H., & Deng, H. (2007) · doi:10.1142/9789812790811_00022
Wnt/Frizzled receptor signaling in osteoporosis
Rawadi, G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760334.019
Key, L. L., & Ries, W. L. (2003) · Elsevier eBooks · doi:10.1016/b978-012286551-0/50021-x
Corr, M. (2011) · CRC Press eBooks · doi:10.1201/b10852-10
Circulating Sclerostin in Bone Sclerosing Disorders
van Lierop, A. H., & Papapoulos, S. E. (2016) · Exposure and Health · doi:10.1007/978-94-007-7745-3_39-1
WITHDRAWN: Endothelin signaling in bone
Kristianto, J., Johnson, M. G., Afzal, R., & Blank, R. D. (2016) · Translational research · doi:10.1016/j.trsl.2016.11.004
Use of Bone Biomarkers After Weight Loss: Example of Bariatric Surgery
Biagioni, M., Mendes, A. L., de Paiva, S. A. R., & Mazeto, G. M. F. D. S. (2015) · Biomarkers in disease · doi:10.1007/978-94-007-7745-3_8-1
SCLEROSTIN IMMUNOREACTIVITY INCREASES WITHIN THE CORTICAL BONE OSTEOCYTES IN THE FEMUR OF AGING MICE
Hamdan, N. A. (2016) · UA Campus Repository (The University of Arizona)
Effects of the Lyme disease pathogen Borrelia burgdorferi on murine bone biology
Tang, T. (2016) · TSpace (University of Toronto)
Functional characterisation of an osteoclast-derived osteoblastic factor (ODOF)
Phan, T. A. (2004) · UWA Profiles and Research Repository (UWA) · Cited by 2
Osteoporosis Treatment: Bone-Forming Agents
Langdahl, B. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65349-7
Using Genetically Engineered Mouse Models to Study Wnt Signaling in Bone Development and Disease
Zhong, Z. A., Ethen, N. J., & Williams, B. O. (2017) · Current human cell research and applications · doi:10.1007/978-981-10-7296-3_1
Van Buchem Disease and Sclerosteosis
Balemans, W., & Hul, W. V. (2009) · Springer eBooks · doi:10.1007/978-3-540-29676-8_3116
Gewinnung und Charakterisierung von osteoblastären Zellen aus dem humanen Alveolarknochen
Dillschneider, D. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6868
Braz, M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-22102018-123623
Transition of Osteoblasts to Osteocytes
Lin, S., Methani, M. M., & Feng, J. Q. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11183-3
Paracrine Modulation of Mechanotransduction
Huang, J., Wang, Z., Brotto, L. S., Varanasi, V. G., Mo, C., & Brotto, M. A. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11214-0
Mannstadt, M., & Wein, M. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00052-x · Cited by 1
Canonical Wnt Mechanisms in Neural Crest Induction
Perfetto, M. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7393
Osteocytes: More Than Just Mechanosensory Cells
Prideaux, M., & Bonewald, L. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11203-6
Martin, M. (2019) · theses.fr (ABES) · doi:10.70675/8122ec8cz7c1fz4dd7z85a7z11a3e3e688c4 · Cited by 1
The effect of bone anabolic stimuli on human osteoblast to osteocyte transition.
Welldon, K. J. (2012) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Pathophysiology of osteoporosis
Streeten, E. A., Jaimungal, S., & Hochberg, M. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00199-6
Aripaka, K. (2019) · DiVA at Umeå University (Umeå University)
Martin, M. (2020) · Queensland University of Technology · doi:10.5204/thesis.eprints.203101
Genetische Analysen in der Osteologie
Rötzer, K., & Uyanik, G. (2021) · rheuma plus · doi:10.1007/s12688-020-00394-8
Dillstrom, D. (2018) · Deep Blue (University of Michigan)
Wnt signaling pathway as a regulator of bone formation and healing.
Elseweidy, M. M., El-Swefy, S. E., Baraka, N. M., & Hammad, S. K. (2021) · Zagazig Journal of Pharmaceutical Sciences/Zagazig Journal of Pharmaceutical Science · doi:10.21608/zjps.2021.64130.1020
Oreka Tx, de paseo con la txalaparta
Urpí, J. (2009) · Integral: Vive mejor en un mundo mejor
Anti-Sklerostin-Therapie aus nephrologischer Sicht – mit einem Fokus auf kardiovaskuläre Sicherheit
Cejka, D. (2021) · Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen · doi:10.1007/s41970-021-00162-w
Rapisarda, L., Gagliardi, M., Bombardieri, C., Procopio, R., Demonte, G., Tosto, F., Gambardella, A., Annesi, G., & Bono, F. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.119265
Sugiyama, T. (2021) · Springer eBooks · doi:10.1007/978-981-16-5613-2_25
Bone Remodeling and Modeling: Therapeutic Targets for the Treatment of Osteoporosis
Langdahl, B. L. (2021) · Springer eBooks · doi:10.1007/978-981-16-5613-2_8 · Cited by 1
BONE DISORDERS: TRANSLATIONAL MEDICINE CASE STUDIES
Stoch, S. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976087.007
Maurizi, A., & Rucci, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00051-7 · Cited by 1
Qian, Y., Yuan, C., Khederzadeh, S., Han, M., Liu, H., Qiu, M.-C., Gao, J., Wang, W., Hou, Y.-P., Chen, G., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4047138
Faculty Opinions recommendation of Osteoporosis: now and the future.
Elisaf, M., & Rizos, C. V. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717991070.793473318
Hereditary Disorders of the Skeleton
Whyte, M. P. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00067-8
Sclerostin and Wnt Antagonists: Implications for Osteoporosis Therapies
Ke, H. Z., Li, X., Suen, P. K., Qin, L., & Holdsworth, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11547-8
Osteoblasts in Human Skeletal Diseases
Findlay, D. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11174-2
Session 10: Applied technologies I
(2008) · Human Antibodies · doi:10.3233/hab-2007-161-210
Johnson, M. L., & Recker, R. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50018-4
Use of Bone Biomarkers After Weight Loss: Example of Bariatric Surgery
Biagioni, M., Mendes, A. L., de Paiva, S. A. R., & Mazeto, G. M. F. D. S. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7693-7_8
TGF-β and Genetic Skeletal Diseases
Wang, X., & Cao, X. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11574-0
WNT/_-Catenin Signaling Modulating Osteoarthritis
Corr, M. (2011) · CRC Press eBooks · doi:10.1201/b10852-8
Circulating Sclerostin in Bone Sclerosing Disorders
van Lierop, A. H., & Papapoulos, S. E. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7693-7_39
Sclerosteosis ( SOST / BEER , 17 q 12‐ q 21)
(2004) · Wiley eBooks · doi:10.1002/0471684228.egp11239
Qian, Y., Guan, P.-L., Khederzadeh, S., Liu, K.-Q., Yuan, C., Han, M., Liu, H., Qiu, M.-C., Gao, J.-H., Wang, W., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4181710
Loss of GFAP causes optico-retinal dysplasia and vision impairmentPreprint
Sarusie, M. V., Rönnbäck, C., Jespersgaard, C., Baungaard, S., Ali, Y., Kessel, L., Christensen, S. T., Brøndum‐Nielsen, K., Møllgård, K., Rosenberg, T., et al. (2022) · medRxiv · doi:10.1101/2022.11.09.22282105
Banu, S., Puzhankara, L., Kedlaya, M. N., Varghese, J., & Ramanarayanan, V. (2022) · Cumhuriyet Dental Journal · doi:10.7126/cumudj.1110413
Melaku, L. S. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.50.007982
Chen, Y., Jiang, N., Ling, S., Liu, J., Lin, Y., Zhou, R., Yao, Z., Guo, X., & Xia, X. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4593804
Vitamin D activity in osteoblasts and osteocytes
Anderson, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91386-7.00030-1
Rôle de l'axe ATX/LPA dans le remodelage osseux
Demesmay-Michaud, L. (2022) · theses.fr (ABES) · doi:10.70675/91849ed6z7e5bz4d58z8364ze70b295a046f
Osteoporosis treatment: Bone-forming agents
Langdahl, B. L., Mäkinen, V.-N., & Sølling, A. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00053-4
Disorders of Bone Density, Volume, and Mineralization
Pyeritz, R. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-812531-1.00022-1
Bone cells: Osteoblast/osteoclast/osteocyte
Ucci, A., & Rucci, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00158-8
Ergin, M. O., Ercıyas, K., Tarakçıoğlu, M., & Ulusal, H. (2024) · European Journal of Therapeutics · doi:10.58600/eurjther2370
“It is known to strongly suppress bone growth [15,16].”
Acquaviva, F., Bruno, G., Palladino, F., Rubino, A., Russo, C., Pandolfi, M., Covelli, E. M., Evangelista, E., Falco, L. D., Tirozzi, A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178175
“Sclerosteosis is caused by biallelic pathogenic variants in SOST [5], which result in the loss of a functional C-terminal domain necessary for the secretion of sclerostin protein from the endoplasmic reticulum [6].”
Sclerostin levels in patients with acromegaly
Wydra, A., Wydra, J., Rogowska, J., Zgliczyński, W., & Czajka-Oraniec, I. (2025) · Endokrynologia Polska · doi:10.5603/ep.105450
Molecular mechanisms and clinical implications of Wnt pathway inhibition
Wang, R., & Wang, P. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152806 · Cited by 2
Þórólfsdóttir, R. B., Sveinbjörnsson, G., Eldjárn, G. H., Aegisdottir, H. M., Styrkársdóttir, U., Grétarsdóttir, S., Steinthórsdóttir, V., Tragante, V., Oddsson, Á., Stefánsdóttir, L., et al. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf177
Osteocytes in Mechanosensing: Insights from Mouse Models and Human Patients
Watanabe, K., & Ikeda, K. (2010) · Springer eBooks · doi:10.1007/978-4-431-89757-6_9
“Sost, encoding sclerostin, was identified as the causative gene of the autosomal recessive disease sclerostenosis, and has been shown to be a negative regulator of bone formation through its anti-Wnt function (Balemans et al. 2001; Brunkow et al. 2001; Winkler et al. 2003; van Bezooijen et al. 2004).”
BackgroundHuang, J., Ma, T., Wang, C., Wang, Z., Wang, X., Hua, B., Jiang, C., & Yan, Z. (2024) · Figshare · doi:10.6084/m9.figshare.27129318
Regulation of the expression of Sclerostin in periodontal fibroblasts
Gruber, M. (2011) · University of Vienna · doi:10.25365/thesis.14876
Huang, J., Ma, T., Wang, C., Wang, Z., Wang, X., Hua, B., Jiang, C., & Yan, Z. (2024) · Figshare · doi:10.6084/m9.figshare.27129321
TALLYHO/JngJ as a model for type 2 diabetes-induced bone disease
Emini, L. (2023) · Qucosa (Saxon State and University Library Dresden)
Nmp4 Suppresses Osteoanabolic Potency
Heim, C. N. (2023) · IUScholarWorks (Indiana University) · doi:10.7912/403z-z919
Multi‐Omics Analysis Reveals the Molecular Subtypes and Confirmed the GREM1 as the Core Gene
Li, Z., Huang, H., Zhai, K., & Li, B. (2026) · The Journal of Gene Medicine · doi:10.1002/jgm.70067
Sterner, E. A. (2026) · Science & Technology Libraries · doi:10.1080/0194262x.2026.2638176
“The gene identified by Brunkow, Ramsdell, and their team, named Foxp3, belongs to a family of transcription factors known as forkhead/winged-helix proteins and produces a protein that plays a crucial role in keeping the immune system balanced and functioning properly (Brunkow et al. 2001b).”
Růžičková, O. (2024) · Clinical Osteology · doi:10.36290/clo.2024.008
Johnson, M. L. (2026) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjag058
Whyte, M. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00049-9
Huybrechts, Y., & Hul, W. V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00039-6 · Cited by 1
Introduction to genetics of skeletal and mineral metabolic diseases
Newey, P. J., Lovegrove, C. E., Howles, S., Whyte, M. P., & Thakker, R. V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00015-3
Kitase, Y., Prideaux, M., Bellido, T., Pajevic, P. D., & Bonewald, L. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00043-8
Gene discoveries and novel therapies in monogenic low and high bone mass disorders
Hendrickx, G., Padidela, R., & Mäkitie, O. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00022-0
Skeletal muscle growth and maintenance depend on BMP signaling
Schirwis, E. (2014) · theses.fr (ABES) · doi:10.70675/7234357bz1f9dz4a42za02cz799ec1dedf12
Role of bone microarchitecture and hereditary determinants of bone fragility
Nagy, H. A. A. M. (2013) · theses.fr (ABES) · doi:10.70675/950dc642z816dz4693za1e6za963d3d33fff
Sclérostine et insuffisance rénale chronique : étude clinique
Pelletier, S. (2015) · theses.fr (ABES) · doi:10.70675/1b5b82ffzde62z418ezab0fz9f3f09ffb607
Marqueurs de risque des complications de la maladie rénale chronique
Desjardins, L. (2015) · theses.fr (ABES) · doi:10.70675/67e7f80fz7263z4373zb9eez6d08d7f8f9b7
Patrier, L. (2014) · theses.fr (ABES) · doi:10.70675/856fba23zd92az4508z88b4z4a6cd1d739dd
Metadata
- Authors
- Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., Alisch, R. S., Gillett, L., Colbert, T., Tacconi, P., Galas, D., Hamersma, H., Beighton, P., & Mulligan, J. T.
- Affiliations
- University of Cape Town (ZA)
- University of Cagliari (IT)
- Corresponding author
- Brunkow, Mary E.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 68
- Issue
- 3
- Pages
- 577-589
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1274471
- OpenAlex
- W2037750372
- Cited by
- 1,011
- References
- 50
- Citations by year
- 2026: 24 · 2025: 21 · 2024: 32 · 2023: 27 · 2022: 36 · 2021: 53 · 2020: 52 · 2019: 46 · 2018: 50 · 2017: 56 · 2016: 65 · 2015: 61 · 2014: 58 · 2013: 60 · 2012: 56
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4523 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Keywords
- sclerosteosis, SOST gene, skeletal dysplasia, cystine knot proteins, bone homeostasis, skeletal overgrowth, nonsense mutation, splicing mutation, founder effect, Afrikaner population, bone formation regulation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Bone Diseases, Chromosome Mapping, Chromosomes, Human, Pair 17, Consanguinity, Cystine, Female, Genetic Markers, Homozygote, Humans, Male, Molecular Sequence Data, Netherlands, Pedigree, Proteins, Recombination, Genetic, Sclerosis, Senegal, South Africa, Conserved Sequence, Alternative Splicing, Bone Morphogenetic Proteins, Mutation, Missense, Black People, White People, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.